We repo rt a case of cutaneous T-cel/lymph oma in which the firs t sign of disease was involvement of the superior auricular helix. A review of the literature reveals that Tcell lymphoma of ten presents cutaneously, but it usually does not involve the ear, and an auricular lesion is rarely the first sign. The uncommon natur e ofthis presentation, in addition to the potential need for multiple biopsiesfor a tissue diagnosis, can lead to a delay in diagnosis. When evaluating skin lesions in the head and neck, a high index ofsuspicionfor cutaneous T-cell lymph oma is a keyfa ctor in its early diagnosis.
The re are only a few reports in the literature of T-cell lymph oma that involved the ear. Ear involvement was first reported in 1971 by Strahan and Calcaterra.' The y described a patient who had simult aneous involvement of the face, oroph arynx, and external auditory canal. In 1975, Fenwick described a patient who had T-celllymphoma involving the external auditory canal.' Involvement of the auricular helix has not been previously described in the literature . Our case is unique in another respect, becau se it is the first reported case in which a patient had only auricula r invol vement.
Case report
An 87-yea r-old white man came to the emergency department at the Madigan Army Medic al Center in Tacoma, Wash., compl aining of left otalgia. The pain had been present for 1 month and had worsened over the previous week. The re was no history of trauma , insect bites, or infection. The patient' s medical history was negative for cancer, diabete s, and other potentially immunocompromising diseases. He denied having fever, chills, otorrhea, and vertigo.
The patient was seen in the otolaryngology clinic the following day. Examination of the left ear revealed an ulcerative lesion with purul ent drainage on the superior helix. Labo ratory values at that time showed a white blood cell count of7 .2 x 1Q9/L with a normal differential, a hemoglobin of 14.0 g/dl, and a hem atocrit of 42.5 %. Liver enzyme s and electrolytes were within normal limits. His chest x-ray was normal.
The patient was placed on oral antibiotics and the lesion was biopsied. The initial biop sy showed skin with ulceration and an inflammatory infiltrate within the superficial dermis. The inflammatory comp onent was made up of a mixed popula tion of lymphocytes and scattered eosinophil s. Man y feature s of chondroderma titis nodularis chronica helicis were present , but no degener ative carti-lage was seen. Immunohistochemical staining did not reveal kappa or lambda monoclonality within the B cells. T-cell markers showed a phenotypically normal T-cell population, suggesting a florid reactive process and not malignancy. The patient was continued on topical and oral antibiotics.
Approximately 5 weeks after his initial visit, the patient was admitted to the adult observation unit for unresolved left perichondritis. At that time, cultures demonstrated Staphylococcus aureus and Serratia marcescens. Consultation was obtained with an infectious disease specialist, who recommended appropriate intravenous antibiotics, which were initiated. The patient underwent a second biopsy, which showed a dense infiltrate of small to large transformed lymphocytes, some plasma cells, and very few eosinophils. Following 5 weeks of IV antibiotic therapy, the auricular lesion had not improved (figure 1). As aresult, the patient was taken to the operating room for an excisional biopsy and primary reconstruction, with good results (figure 2). Following surgery, the results of immunohistochemistry for Band T-cell markers became available. They revealed the presence of a predominant T-cell phenotype and some admixed B cells. The specimen was sent to the Armed Forces Institute of Pathology in Washington, DC, for T-cell receptor (TCR) gene rearrangement studies. These studies demonstrated dominant monoclonal rearrangements of the TCR I3 and y genes.
The final pathology results of a third biopsy revealed a dense, diffuse infiltrate of atypical lymphocytes that extended from the mid-dermis through the underlying subcutaneous tissue and onto the adjacent cartilage ( figure 3 ). The atypical lymphocytes were predominantly intermediate in size, although numerous small and large atypical cells were also present. The cells were characterized by moderate amounts of amphophilic cytoplasm, irregular and convoluted nuclei, and distinct nucleoli ( figure 4 ). Immunohistochemical staining revealed that the neoplastic cells were T cells; they were CD45-, CD3-, and CD45RO-positive. TCR gene rearrangement studies were again performed on paraffin-embedded tissue, and dominant monoclonal rearrangements of the TCR 13 and y genes were again detected. The morphologic, immunohistochemical, and gene rearrangement studies supported the diagnosis of cutaneous T-cell lymphoma. Discussion T-cell lymphoma has been reported to involve many areas of the head and neck, but an initial cutaneous presentation is less common. A review of the English-language literature reveal s only three reports of cutaneous T-celllymphom a involvin g the extern al auditory canal'? and only two cases involving the cheek .v' Our own review of the literature on cutaneous T-cell lymphom a involving the auricular helix failed to discover any similar case.
Class ic cutaneous T-cell lymphom a generally , but not invariably, evolves through three defined clinical stages: the patch, plaque, and tumor stages. Durin g the patch stage, lesion s are no more than barely raised erythematous areas, often with adherent scales. These lesions are often confused with eczematou s dermatitis. Early cutaneous Tcell lymphoma is often refractory to topical anti-inflammatory medications, and thus it usually causes clinical concern and demand s a subsequent biopsy.
Durin g the plaque stage, lesions are raised , indur ated, and variable in color , ranging from pink to red to brownpurple. Well-defined plaques are common, and scaling and pruritu s are often more prominent than they are in the patch stage. Patche s and plaques of cutaneous T-cell lymphoma are relatively indolent, and they can progress over many years without ever spreadin g systemically.
If the disease goes untre ated, tumor-stage nodule s will eventu ally develop . These nodules are firm and domeshaped, and they often affect the face, scalp, and body folds. The presence of tumor-stage nodules correlate s with the visceral spread of the disease, and the prognosis is poor. Tumors infrequently arise de novo, a situation that is referred to as the "tumor d'ernblee" form of cutaneou s T-cell lymphom a. . Rat HepatocyteDNA RepairAssay Mi cronucleus Test (Mice) DominantLethalTest (Mice) tone-term carcinogenicity studies in mi ce and rats have been completed for ciprofloxacin. After dail y oraldoses of 750 mglkg (mice) and250 mglkg (rats) were administered forupto 2 years, therewas noevidencethatclprotloxaclnhad anycarcinogenicor tumorigenic effects in these species. No long term studies of CIPRO' HC OTiC suspension havebeen performed to evaluatecarcinogenic potential. Fertili ty studies performed in rats at oral doses of ciprof loxacin upto 100mg/kg/day reveal ed noevidence of impai rment.This would beover1000 times the maximum recommended clinical dose of ototopical clprotloxacin based uponbodysurface area, assumingtotal absorption of ciprofloxacin from theear of a patienttreated with CIPRO' HC OTICtwice perday. Long term studies have notbeen performed to evaluatethe carcinogenic potentialor theeff ect onfertili ty oftopical hydrocorti sone. Mutagenici ty studieswith hydrocorti sonewere negative. Pregnancy: Teratogenic Effects. Pregnancy Category C: Reproducti onstudies have been perf ormed in rat s and miceusingoral doses of upto 100 mglkg and IVdoses upto 30 mglkg and have revealed no evidence of harm to the fetus as a result of ci profloxacin.Inrabbits, ciprofloxacin (30and 100 mglkg orally)produced gastrointestinal disturbancesresul ting in maternal weight loss and an increased incidence of abortion, butnoteratogenicitywasobserved ateither dose.Aft erintravenousadministrati onof doses upto20mglkg, no maternal toxicity was produced in the rabbit, and no embryotoxicity or teratogenicity was observed. Corticosteroids aregenerall y teratogenic in laboratory animalswhenadministered systemicallyat rel atively low dosage levels. The mor e potent corticosteroidshave beenshown to beteratogenic aft erdermalapplication in laboratoryani mals. Animalreproductionstudies havenot beenconducted withCIPRO' HC OTIC.Noadequateandwell controlled studies have been performed in pregnant women. Cautionshould be exercised when CIPRO' HC OTICis used by apregnantwoman. Nursing Mothers: Ciprofloxacin is excreted in human mil k with systemic use. It is not known whether cipr otloxacinis excreted in humanmil k following topical oti c administration.Because of the potential for serious adverse reactions in nur sing infant s, a decisi on should be made whetherto discont inue nursing or to discont inuethe drug, takinginto account the importance of the drug to the mother. Pediatric use: The safetyand efficacy of CI PRO' HCOTIChave beenestablished in pediatri c pati ent s 2 years and older (131 patient s) in adequate and well-controlled clinical trials. Alth oughnodataareavail ableonpati ent s lessthan age 2years,thereare noknown safety concernsor differen ces inthedisease process inthis populationwhich would preclud euseof this product in pati ent s oneyear and older. See DOSAGE AND ADMINISTRATION. ADVERSE REACTIONS InPhase3 clinical trial s,atotalof 564 pati ent sweretreatedwith CIPRO' HC OTIC. Adverseevents with at leastremoterel ationship totreatmentincludedheadache (1. 2%) andprur itus (0.4%) . The foll owing treatment-related adverse events were each reported in a single patient: mig raine, hypesthesia, paresthesi a, fungal dermatitis, cough, rash, urti cari a, and alopecia. NDC0065-8531 -10 CI PRO' is a registered trademark of BayerAG. The histologic diagnosis of cutaneous T-cell lymphoma in the patch stage is often one of the most difficult diagno ses that a pathologist is required to make . These lesions resemble a mild inflammatory dermatosis, and they feature a periv ascular lymphocytic infiltrate in the papillary dermi s and a mildly hyperpl astic nonspongiotic epidermis that can exhibit focal hyperkeratosis or parakerato sis. Sparse numbers of atypical lymp hocytes are scattered within the papillary dermis and epidermis.These lymphocytes can appe ar singly or in small aggrega tes ( figure 3) .
The plaque stage is characterized by a band-like infiltrate of polymor phous atyp ical lymphocytes within the papillary and superficial reticular dermis (figure 3). The larger transformed lymphocytes have hyperchromatic nuclei with irreg ular, convo luted nuclear membranes. Small aggregates of atypical lymphocytes are identified within the epidermis (Pautrier's microabscesses).
The tumor stage is often referred to as the 11011epidermotropic stage because the papillary dermis and overlying epidermis are typically spared. Sheets and nodule s of neopla stic lymphocytes are present within the reticu lar dermis . The lympho cytes range from small to large transformed cell s, with admi xed immunoblasts and even Reed-Sternberg-like cell s. As noted earlie r, the lymphocytes have hyperchromatic nuclei with the classic con voluted , cerebriform nuclea r membranes. In the tumor stage, localized cutaneou s T-cell lymphoma is associated with large reactive lymphoid infiltrates around the periphery of the lymphoma, and repeat biopsies are often necessary to obtain adequate diagnostic tissue .
Disease staging depends on the extent of cutaneous and hematologic involvement and on the presence or absence of nodal and/or visceral involvement. Because survival 396 time is close ly related to the presence or absence of extracutaneou s disease, all patients should undergo a thorough workup . This includes a complete physical examination with emph asis on skin and lymph node assessment, examination of peripheral blood for mononuclear cell abnormalities, and imaging studies, including a chest x-ray. If clinical suspicion for visceral disease exists, ultrasonography and/or comp uted tomography can help confirm extracutaneous disease. Dissemination to lymph nodes and viscera is seen at autopsy in 71% of cases ."
The case we report in this article is significant for two reasons. First, it represents an unusual location for cutaneous T-cell lymphoma. Therefore, a high index of suspicio n should be maintaine d for occult malignancies in patients who presen t with presumptive cutaneo us infections that do not respond to antibiotic thera py. Second, it demons trates the difficulty of making a tissue diagnosis. The reason for this might be the reactive lymphoid infiltrate located in the periphery of the lymphoma. A repeat biop sy might be nece ssary to make a definitive diagnosis. In our patient, an excision of the lesion was necessary to arrive at a diagnosis. Our patient was treated postoperatively with a total dose of 4,000 cOy of 12 MeV electronbeam radiation to the left auricle and ipsilateral neck . He remains free ofdisease 10 months following the initiation of therapy.
